Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872452 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 9 Pages |
Abstract
Conclusions: Surgery plus FSR is safe and effective. FSR focused to the target volume seems more suitable than standard radiotherapy, and standard fractionation reduces the risk of optic neuropathy sometimes observed after single-dose radiosurgery. Therefore, FSR allows us to consider combined transrhinoseptal surgery and early radiotherapy, with a curative goal without patient selection.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Philippe M.D., Nicolas M.D., Brigitte M.D., Ph.D., Jean M.D., Herve M.D., Annie-Claude M.D., Celine M.D., Arnaud M.D., Mary-Helene M.D., Bernard M.D., Philippe M.D., Ph.D., Iab M.D., Charles PhD., Pascal M.D.,